1. Home
  2. ZJYL vs FEMY Comparison

ZJYL vs FEMY Comparison

Compare ZJYL & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

N/A

Current Price

$1.91

Market Cap

18.6M

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$3.96

Market Cap

21.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZJYL
FEMY
Founded
2006
2004
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
21.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ZJYL
FEMY
Price
$1.91
$3.96
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
16.8K
48.8K
Earning Date
08-20-2025
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.71
EPS
N/A
N/A
Revenue
N/A
$2,293,313.00
Revenue This Year
N/A
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
$18.40
N/A
Revenue Growth
N/A
40.77
52 Week Low
$0.10
$0.29
52 Week High
$4.50
$6.29

Technical Indicators

Market Signals
Indicator
ZJYL
FEMY
Relative Strength Index (RSI) 36.99 60.93
Support Level $1.64 $0.47
Resistance Level $2.69 $6.29
Average True Range (ATR) 0.12 0.41
MACD -0.06 -0.13
Stochastic Oscillator 13.25 35.94

Price Performance

Historical Comparison
ZJYL
FEMY

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: